Top section
Top section
◆ UAE issuers leave emerging markets lable behind ◆ What Blue Owl can teach about private credit for the masses ◆ A bump in the road for UK bridging lenders on the way to securitization
Liquidity event at American manager comes at fraught time for industry
Investment bank, like the group, wants to diversify outside France, and will lead with its strongest suit, real assets
More articles
More articles
More articles
-
India’s Emcure Pharmaceuticals has returned to the loan market after four years, seeking a small amount of $34m. -
Loan bankers say that borrowers, including those in emerging markets, are still interested in green financing, though they say it has been “drowned out” by chatter around more pressing market concerns, such as Covid-19 financing and global political uncertainty.
-
A number of investment banks have withdrawn from arranging deals in the Schuldschein market, according to data sets seen by GlobalCapital, as international supply shrinks and institutional focus moves elsewhere.
-
Professional services firm Alvarez & Marsal has hired a senior figure from Deloitte to help grow its debt advisory business in European private credit.
-
Target Healthcare, a care home real estate investment trust, has renegotiated £170m of loans, with the borrower using risk free rates instead of Libor as a benchmark.
-
Asia’s capital markets started on a positive note on Monday following Joe Biden’s presidential election victory in the US.
Sub-sections
